Lixte Biotechnology Holdings, I

Historical 13F Holders

Symbol
NMAD
CUSIP
539319301
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 539319301 since 12/18/2024, newest first.

Filer % of Class Filed
Vanguard Capital Management LLC 13G 5.0% 7/31/2026
Event 6/30/2026
Strategic EP, LLC 13G
5.1% 6/9/2026
Event 6/4/2026
Orca Capital AG 13G/A Amendment 1 4.5% 2/18/2025
Event 2/14/2025
Intracoastal Capital LLC 13G
4.99% 2/18/2025
Event 2/11/2025
Orca Capital AG 13G 8.1% 2/13/2025
Event 2/11/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q2 18 1.98 M $14.6 M
2026 Q1 14 733 k $2.25 M
2025 Q4 17 755 k $2.97 M
2025 Q3 16 439 k $2.21 M
2025 Q2 11 164 k $148 k
2025 Q1 10 300 k $385 k
2024 Q4 11 298 k $608 k
2024 Q3 8 216 k $409 k
2024 Q2 7 178 k $424 k
2024 Q1 9 153 k $515 k
2023 Q4 8 121 k $285 k
2023 Q3 7 38.0 k $80.8 k
2023 Q2 6 17.3 k $101 k